Health IT vendor Veradigm, formerly Allscripts, announced a collaboration with healthcare data ecosystem HealthVerity that will leverage registry data to advance chronic disease research. The ...
CHICAGO & PHILADELPHIA--(BUSINESS WIRE)--Veradigm ®, a leading provider of healthcare data and technology solutions (NASDAQ: MDRX), and HealthVerity ®, a leader in ...
With the introduction of seven new disease-specific registry datasets, Veradigm is enabling deep, targeted research to drive innovation and enhance real-world clinical insights Veradigm’s Clinical ...
Veradigm, formerly known as Allscripts, has partnered with HealthVerity to advance research and improve care for patients with cardiovascular disease and diabetes. Under the partnership, Veradigm will ...
Registry to Enable Prospective Safety Study “DISCOVER-HCM” to Track Long-Term Safety and Effectiveness of Mavacamten in Patients with Symptomatic, Obstructive Hypertrophic Cardiomyopathy BRISBANE, ...
Veradigm™, an Allscripts (NASDAQ:MDRX), business unit and a leader in providing next-generation healthcare data solutions and systems, is leveraging its capability to communicate directly with a broad ...
With the introduction of seven new disease-specific registry datasets, Veradigm is enabling deep, targeted research to drive innovation and enhance real-world clinical insights CHICAGO, February 18, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results